The Regulation of Tumor Suppressor Genes by Oncogenes
Tumor suppressor genes (TSGs) and oncogenes represent the ying and the yang of cell growth, differentiation, and survival control. TSGs such as p53, the retinoblastoma (RB) gene product, and the cyclin kinase inhibitor (CKI) proteins p21 Cip-1/WAF1/mda6 (p21), p27 Kip-1 (p27), p16 INK4a (p16), and p19 ARF (p19), play the role of negative regulators of the cell cycle (1 –5 ). In contrast, mutation of protooncogenes such as the epidermal growth factor receptor (EGFR) (6 ), ErbB2 (Neu) (7 ), Ras (8 ,9 ), Raf-1 (10 ), PTEN (11 ,12 ), MKP-1 (13 ), and c-Myc (14 ) can promote cell cycle progression, in part by abrogating the negative regulation of the cell cycle by tumor suppressor genes.
- Determination of Tumor Ferritin Concentration in Breast Cancer
- MicroRNA Profiling in Ovarian Cancer
- Recombinant Adenoviruses for In Vivo Expression of Antibody Fragments
- Analysis of Targets and Functions Coregulated by MicroRNAs
- A Molecular Technique Useful in the Detection of Occult Metastases in Patients with Melanoma: RT-PCR Analysis of Sentinel Lymph
- Cancer Gene Therapy With Heat Shock Protein-65 Gene
- Magnetic Aerosol Targeting of Nanoparticles to Cancer: Nanomagnetosols
- 干细胞和衰老的终结(第四部分)
- B7-H Abnormalities in Melanoma and Clinical Relevance
- Use of Tumor-Activated Hepatic Stellate Cell as a Target for the Preclinical Testing of Anti-Angiogenic Drugs Against Hepatic Tu